tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MYGN Stock Latest News

Is MYGN a Buy, Before Earnings?
Pre-EarningsIs MYGN a Buy, Before Earnings?
5d ago
MYGN
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
PremiumPress Releases
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
19d ago
MYGN
Myriad Genetics announces new study published in Prenatal Diagnosis
PremiumThe Fly
Myriad Genetics announces new study published in Prenatal Diagnosis
19d ago
MYGN
Myriad reports results from real-world study of patients with depression
PremiumThe Fly
Myriad reports results from real-world study of patients with depression
26d ago
MYGN
Myriad Genetics issued patent for MRD
PremiumThe Fly
Myriad Genetics issued patent for MRD
1M ago
MYGN
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
PremiumPress ReleasesMyriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
1M ago
MYGN
Myriad Genetics announces patent granted for SneakPeek Snap device
PremiumThe Fly
Myriad Genetics announces patent granted for SneakPeek Snap device
2M ago
MYGN
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
PremiumPress Releases
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
2M ago
MYGN
Myriad Genetics price target raised to $28 from $25 at Raymond James
PremiumThe Fly
Myriad Genetics price target raised to $28 from $25 at Raymond James
2M ago
MYGN
Myriad Genetics price target raised to $26 from $23 at TD Cowen
PremiumThe Fly
Myriad Genetics price target raised to $26 from $23 at TD Cowen
2M ago
MYGN
Myriad Genetics price target raised to $17 from $14 at JPMorgan
PremiumThe Fly
Myriad Genetics price target raised to $17 from $14 at JPMorgan
2M ago
MYGN
Myriad Genetics sees FY24 adjusted EPS 0c-5c, consensus (1c)
PremiumThe Fly
Myriad Genetics sees FY24 adjusted EPS 0c-5c, consensus (1c)
2M ago
MYGN
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance
PremiumPress ReleasesMyriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance
2M ago
MYGN
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
PremiumPress Releases
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
2M ago
MYGN
Myriad Genetics, NCCHE collaborate on SCRUM-MONSTAR-SCREEN-3 study
PremiumThe Fly
Myriad Genetics, NCCHE collaborate on SCRUM-MONSTAR-SCREEN-3 study
2M ago
MYGN
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MYGN
Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
PremiumPress Releases
Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
2M ago
MYGN
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health
PremiumPress Releases
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health
3M ago
MYGN
Myriad Genetics management to meet with BTIG
PremiumThe Fly
Myriad Genetics management to meet with BTIG
3M ago
MYGN
Myriad Genetics management to meet with BTIG
PremiumThe FlyMyriad Genetics management to meet with BTIG
3M ago
MYGN
Myriad Genetics management to meet with BTIG
PremiumThe Fly
Myriad Genetics management to meet with BTIG
3M ago
MYGN
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
PremiumPress Releases
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
3M ago
MYGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >